Purpose <p>When confronted with healthy functional impairments, the attribution of disease-induced distress plays a key role in the prognosis of health outcomes. This study examined the effects of an attribution-related intervention, namely WeChat-based EPIC (enter, practice, intensify, consolidate) training, on health-related quality of life (HRQoL), attribution, and life attitude in women newly diagnosed with breast cancer.</p> Methods <p>Eligible patients were recruited using convenience sampling and randomly assigned to the intervention or control group via stratified block randomization. The former received WeChat-based EPIC training plus routine nursing care for 6&#xa0;months. The latter received only routine nursing care. HRQoL (primary indicator), attribution and life attitude (secondary indicators) were measured using the Functional Assessment of Cancer Therapy-Breast version 4.0 (FACT-Bv4.0), Attributional Style Questionnaire (ASQ) and Life Attitude Self-rating Questionnaire for Breast Cancer (LASQ-BC), respectively. A linear mixed model was used to examine the score fluctuations at the 1-, 3-, and 6-month intervals relative to the baseline.</p> Results <p>After 6&#xa0;months, the intervention group (n = 84) showed statistically significant higher total scores in the FACT-Bv4.0 [mean difference: −&#xa0;15.01; 95% confidence interval: −&#xa0;17.96, −&#xa0;12.07; <i>p</i> &lt; 0.001], ASQ [−&#xa0;4.16 (−&#xa0;4.45, −&#xa0;3.86); <i>p</i> &lt; 0.001], and LASQ-BC [−&#xa0;6.77 (−&#xa0;8.27, −&#xa0;5.27); <i>p</i> &lt; 0.001] than that of the control group (n = 82). The total scores of the three indicators also showed significant group, time, and group-by-time interaction effects (<i>p</i> &lt; 0.001).</p> Conclusion <p>The WeChat-based EPIC training was an effective intervention for improving HRQoL and psychological health in women newly diagnosed with breast cancer.</p> <p><b>Trial registration:</b> Chinese Clinical Trial Registry <a href="http://www.chictr.org.cn">www.chictr.org.cn</a>, prospectively registered on 11 April 2020, ChiCTR2000031827.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Effects of WeChat-based EPIC training on health-related quality of life, attribution and life attitude in women newly diagnosed with breast cancer: a clinical randomized controlled trial

  • Kaina Zhou,
  • Xiao Wang,
  • Yan Wang,
  • Ailan Liu

摘要

Purpose

When confronted with healthy functional impairments, the attribution of disease-induced distress plays a key role in the prognosis of health outcomes. This study examined the effects of an attribution-related intervention, namely WeChat-based EPIC (enter, practice, intensify, consolidate) training, on health-related quality of life (HRQoL), attribution, and life attitude in women newly diagnosed with breast cancer.

Methods

Eligible patients were recruited using convenience sampling and randomly assigned to the intervention or control group via stratified block randomization. The former received WeChat-based EPIC training plus routine nursing care for 6 months. The latter received only routine nursing care. HRQoL (primary indicator), attribution and life attitude (secondary indicators) were measured using the Functional Assessment of Cancer Therapy-Breast version 4.0 (FACT-Bv4.0), Attributional Style Questionnaire (ASQ) and Life Attitude Self-rating Questionnaire for Breast Cancer (LASQ-BC), respectively. A linear mixed model was used to examine the score fluctuations at the 1-, 3-, and 6-month intervals relative to the baseline.

Results

After 6 months, the intervention group (n = 84) showed statistically significant higher total scores in the FACT-Bv4.0 [mean difference: − 15.01; 95% confidence interval: − 17.96, − 12.07; p < 0.001], ASQ [− 4.16 (− 4.45, − 3.86); p < 0.001], and LASQ-BC [− 6.77 (− 8.27, − 5.27); p < 0.001] than that of the control group (n = 82). The total scores of the three indicators also showed significant group, time, and group-by-time interaction effects (p < 0.001).

Conclusion

The WeChat-based EPIC training was an effective intervention for improving HRQoL and psychological health in women newly diagnosed with breast cancer.

Trial registration: Chinese Clinical Trial Registry www.chictr.org.cn, prospectively registered on 11 April 2020, ChiCTR2000031827.